Pharmafile Logo
Pharmafocus logo
Advanced Search

Adding veliparib to chemotherapy can extend progression-free survival in in some breast cancer patients

February 1, 2023
Research and Development

It appears that adding veliparib to chemotherapy can extend progression-free survival (PFS) in patients suffering from triple negative breast cancer …

News

NaDeNo’s nanomedicine delivery system inspires hope for peritoneal cancer

February 1, 2023
Research and Development

NaDeNo, a new nanomedicines company and spin-off of the Norwegian science institute SINTEF, has revealed promising results for its cure …

News

FDA approves Axonics’ neurostimulator

February 1, 2023
Medical Communications

US-based medtech company Axonics have received FDA approval for their fourth-generation, rechargeable sacral neuromodulation system for the treatment of chronic …

News

Rare and Orphan disease expert Terebellum to launch incisive Specialty Pharmacy development bulletins, Specialty Pharmaceutical Pulse™

January 31, 2023
Business Services

Global healthcare and business consulting services provider Terebellum is launching a brand-new monthly Specialty Pharmaceutical Pulse™ insights bulletin in the …

News
Press release

Aptar Pharma releases recyclable nasal spray pump

January 31, 2023
Research and Development

US-based drug delivery systems company Aptar Pharma has released its first metal-free, multidose nasal spray. APF Futurity delivers multidose nasal …

News

Amgen launches Amjevita biosimilar on US market

January 31, 2023
Medical Communications

Amgen’s Amjevita (adalimumab-atto) has just launched on the US market, meaning it becomes the first biosimilar to reference the blockbuster …

News

Johnson & Johnson subsidiary loses US bankruptcy bid

January 31, 2023
Medical Communications

A US federal appeals court in Philadelphia has denied pharma giant Johnson & Johnson’s (J&J) subsidiary’s bankruptcy petition, which aimed …

News

First Wave BioPharma announces phase 2 trial

January 31, 2023
Research and Development

Clinical-stage biopharmaceutical company, First Wave BioPharma, has announced that it is planning to begin its phase 2 clinical trial of …

News

Dr. Lin Römer

January 31, 2023
Business Services

Munich, 31 January 2023 – Insempra, a biology-powered company enabling businesses to make superior products in partnership with nature, today …

Appointment

Vertex and CRISPR Therapeutics Announce MHRA Marketing Authorisation Application Validation for CRISPR/Cas9 GeneEdited Therapy, exagamglogene autotemcel (exa-cel

January 30, 2023
Business Services

London, UK and ZUG, Switzerland, January 27, 2023 – Vertex Pharmaceuticals (Europe) and CRISPR Therapeutics (NASDAQ: CRSP) today announced that …

News
Press release

BEXIMCO PHARMACEUTICALS LIMITED Half Year Results 2022-23

January 30, 2023
Business Services

Beximco Pharmaceuticals Limited (“Beximco Pharma”, “BPL” or “the Company”; AIM Symbol: BXP, LEI No.: 213800IMBBD6TIOQGB56), the fast-growing manufacturer of generic …

News
Press release

Kelso Pharma announces first product launch

January 30, 2023
Business Services

30th January 2023: Kelso Pharma, the growing UK based specialty pharma business, has announced its first product launch with the …

News
Press release

Pharmacists say England is not yet unlocking potential of self-care, with 77% backing the idea of a National Self-Care Strategy

January 30, 2023
Business Services

London, 30 January 2023. Today, a new report by Sanofi, an innovative global healthcare company, calls on the Government to …

News
Press release

Pfizer denies purposely mutating COVID-19 virus

January 30, 2023
Medical Communications

Big Pharma company Pfizer has publicly denied allegations that it is deliberately mutating the COVID-19 virus in order to develop …

News

FDA suggests individual risk assessments for blood donations to secure US blood supply

January 30, 2023
Medical Communications

The FDA has announced that it is suggesting a change from the time-based deferrals for blood donation to an individual …

News

Researchers develop test to predict Alzheimer’s disease years before diagnosis

January 30, 2023
Medical Communications

Researchers at King’s College London’s Institute of Psychiatry, Psychology & Neuroscience (IoPPN) have developed a blood test which can potentially …

News

Chiesi Farmaceutici hires new CEO after $1.48bn Amryst acquisition

January 30, 2023
Business Services

Chiesi Farmaceutici, a family-owned Italian pharmaceutical company, has appointed Giuseppe Accogli as group CEO. This comes after 2020’s $1.48bn acquisition …

News

FDA refuses to regulate CBD, calling on Congress to take charge

January 27, 2023
Medical Communications

The FDA is calling on the US Congress to work with them on a new regulatory pathway for cannabidiol (CBD). …

News

FDA pulls approval of COVID-19 antibody treatment due to inefficacy against variants

January 27, 2023
Medical Communications

The FDA has revoked its approval of AstraZeneca’s Evusheld due to the fact that it is not effective against more …

News

Ipsen reports CHMP negative review for use of palovarotene in EU

January 27, 2023
Research and Development

Ipsen, a biopharmaceutical company focused on medicines in oncology, rare diseases and neuroscience, have been denied marketing authorisation by the …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026